Compounds > olmesartan medoxomil
Page last updated: 2024-09-03

olmesartan medoxomil and Cardiac Remodeling, Ventricular

olmesartan medoxomil has been researched along with Cardiac Remodeling, Ventricular in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, ZC; Wang, JP; Wang, XX; Yu, HY; Zhang, M1
Kasal, DA; Mandarim-de-Lacerda, CA; Neves, MF; Oigman, W1
Fukamizu, A; Hashimoto, M; Ishida, J; Ishimaru, T; Kunita, S; Matsukura, T; Nakamura, A; Nakamura, S; Sugiyama, F; Yagami, K1
Adachi, Y; Fukamizu, A; Garbers, DL; Harada, M; Izumi, T; Kawakami, R; Kishimoto, I; Kuwahara, K; Li, Y; Nakagawa, Y; Nakanishi, M; Nakao, K; Saito, Y; Takahashi, N; Tanimoto, K1
Iwao, H; Izumi, Y; Kim, S; Nakamura, Y; Omura, T; Takeuchi, K; Yoshida, K; Yoshikawa, J; Yoshiyama, M1
Averill, DB; Brosnihan, KB; Ferrario, CM; Gallagher, PE; Ishiyama, Y; Tallant, EA1
Egashira, K; Hiasa, K; Ishibashi, M; Takeshita, A; Tan, C; Zhao, Q1
Gong, G; Hu, Q; Ishibashi, Y; Lee, J; Liu, J; Mansoor, A; Murakami, Y; Ochiai, K; Shimada, T; Wang, X; Zhang, J1
Higaki, J; Matsumoto, K; Moriguchi, A; Morishita, R; Nakagami, H; Nakamura, T; Ogihara, T; Sakonjo, H; Taniyama, Y1

Other Studies

9 other study(ies) available for olmesartan medoxomil and Cardiac Remodeling, Ventricular

ArticleYear
Olmesartan medoxomil reverses left ventricle hypertrophy and reduces inflammatory cytokine IL-6 in the renovascular hypertensive rats.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:24

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Disease Models, Animal; Down-Regulation; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Imidazoles; Inflammation Mediators; Interleukin-6; Male; Olmesartan Medoxomil; Rats; Rats, Wistar; Tetrazoles; Ultrasonography; Ventricular Remodeling

2013
Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor.
    Histology and histopathology, 2008, Volume: 23, Issue:10

    Topics: Allopurinol; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomyopathies; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Imidazoles; Male; Myocardium; NG-Nitroarginine Methyl Ester; Olmesartan Medoxomil; Rats; Rats, Wistar; Tetrazoles; Time Factors; Uric Acid; Ventricular Remodeling; Xanthine Oxidase

2008
Short-term suppression of the renin-angiotensin system in mice associated with hypertension during pregnancy.
    Molecular medicine reports, 2012, Volume: 6, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Female; Fetal Growth Retardation; Hypertension, Pregnancy-Induced; Imidazoles; Male; Mice; Mice, Inbred C57BL; Olmesartan Medoxomil; Placenta; Pregnancy; Renin-Angiotensin System; Tetrazoles; Time Factors; Ventricular Remodeling

2012
Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Circulation, 2002, Sep-24, Volume: 106, Issue:13

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Fibrosis; Gene Targeting; Guanylate Cyclase; Heart Rate; Heart Ventricles; Hypertension; Imidazoles; Mice; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Ventricular Remodeling

2002
Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
    Cardiovascular research, 2003, Volume: 57, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Collagen; Diastole; Drug Therapy, Combination; Echocardiography, Doppler; Imidazoles; Male; Models, Animal; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Thiazepines; Ventricular Remodeling

2003
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomyopathy, Hypertrophic; Coronary Vessels; Disease Models, Animal; Enzyme Induction; Imidazoles; Ligation; Losartan; Male; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ventricular Remodeling

2004
Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 44, Issue:3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cell Division; Chemokine CCL2; Coronary Vessels; DNA-Binding Proteins; Extracellular Matrix Proteins; Gene Expression Profiling; Genetic Therapy; Hypertrophy; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Myosin Heavy Chains; Natriuretic Peptide, Brain; Nonmuscle Myosin Type IIB; Nuclear Proteins; Olmesartan Medoxomil; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Media; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasculitis; Ventricular Remodeling

2004
Functional and bioenergetic consequences of AT1 antagonist olmesartan medoxomil in hearts with postinfarction LV remodeling.
    Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Coronary Vessels; Energy Metabolism; Heart; Heart Failure; Imidazoles; Magnetic Resonance Spectroscopy; Mitochondria; Myocardial Infarction; Olmesartan Medoxomil; Oxygen Consumption; Phosphates; Proton-Translocating ATPases; Renin-Angiotensin System; Swine; Tetrazoles; Ventricular Remodeling

2006
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
    Circulation, 2000, Jul-11, Volume: 102, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Cells, Cultured; Collagen; Cricetinae; Extracellular Matrix; Fibroblasts; Fibrosis; Hepatocyte Growth Factor; Humans; Imidazoles; In Vitro Techniques; Male; Matrix Metalloproteinase 1; Muscle Fibers, Skeletal; Myocardium; Olmesartan Medoxomil; Rats; Tetrazoles; Thiazepines; Ventricular Remodeling

2000